Madopar

We used positron emission tomography (PET) and the 18-flourodeoxyglucose tracer to study cerebral effects of complementary… (More)

OBJECTIVE To search for an effective therapy for treating motor disorder due to Parkinson's disease (PD). METHODS Fifty cases… (More)

In this Danish-Norwegian randomized double-blind parallel-group multicentre study, we compared the therapeutic response of slow… (More)

In a randomised, double-blind cross-over study, objective measures were used to compare the effect of a single oral dose of a… (More)

Urinary salsolinol output had been shown to be lower in Parkinsonian patients than in controls and to increase largely after L… (More)

In an open-label study, we substituted conventional levodopa plus benserazide: 100/25 (Madopar) with a controlled-release form… (More)

Eight healthy male and fasted volunteers received alternatively either one HBS capsule of Madopar 125 or two HBS capsules of… (More)

In an open, uncontrolled study the longterm (9 years) effect of treatment with Madopar® alone (n=377) or in combination with l… (More)

In a clinical trial the effect of L-deprenil, a selective irreversible inhibitor of monoamine oxidase (M.A.O.) "type B" in… (More)

The potentiation of the ami akinetic effect after L-Dopa treatment by an inhibitor of monoamine oxidase (MAO) “B”, Deprenil, has… (More)